Therapy-Specific Considerations I-III (from the RPT Curriculum Supplement Series)
Topics Covered:Therapy-Specific Considerations I - Therapy-Specific Considerations for Lu-PSMA-617—Jeff M. Michalski, MD, MBA, FASTRO
Category
  • Physics
  • Radiobiology
  • Radiopharmaceutical Therapy
Format
  • onDemand
  • Webinars
Credits
  • 5.00 AMA PRA Category 1 Credit™
  • 5.00 Certificate of Attendance
Cost $449.00
Stereotactic Body Radiation Therapy for Spinal Metastases: A Practical Case-based and Patient-Focused Discussion of the New Standard of Care
Recent publications have established SBRT as the standard of care in painful spine metastases. As a result, spine SBRT is being increasingly utilized in both academic and community practices, rendering this educational activity timely.
Category
  • Central Nervous System
  • SBRT
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Advanced Quantitative Imaging Techniques for Personalized Radiotherapy and Lung Toxicity Avoidance
This activity provides an in-depth exploration of advanced quantitative imaging techniques for personalized radiotherapy, focusing on addressing barriers to clinical implementation and improving the management of lung toxicity.
Category
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Certificate of Attendance
Cost $229.00
Combined Modality Therapy for Lymph Node Positive Prostate Cancer
Historically, the management of lymph node positive prostate cancer was limited to androgen deprivation therapy, but increasing data now support the use of multimodality therapy. As treatment options have expanded, patient-centered decision making has become increasingly complicated.
Category
  • Genitourinary
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $0.00
Lessons From HyTEC: Brain Necrosis, Optic Neuropathy and Brachial Plexopathy After Stereotactic Radiotherapy
HyTEC (Hypo-fractionated or “Hy”-dose per fraction, Treatment Effects in the Clinic) was an American Association of Physicists in Medicine-led initiative focusing on hypofractionated SBRT/SABR and stereotactic radiosurgery in adults.
Category
  • Central Nervous System
  • SBRT
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Expanding the Scope of Radiation Therapy for Nonmalignant Diseases
This series provides an overview of historical and contemporary indications for radiation therapy in the treatment of nononcological conditions such as ventricular tachycardia, plantar fasciitis, Dupuytren's and Ledderhose diseases, osteoarthritis, and functional brain disorders.
Category
  • Nonmalignant RT
Format
  • onDemand
  • Webinars
Credits
  • 6.50 AMA PRA Category 1 Credit™
  • 6.50 Certificate of Attendance
Cost $449.00
Pushing the Boundaries: Re-Irradiation for Pediatric Brain Tumors
Over the last 10 years, new studies have emerged demonstrating efficacy and safety of re-irradiation for children with recurrent brain tumors.
Category
  • Central Nervous System
  • Pediatric
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $0.00
The Role for Consolidative Local Therapy in Stage IV Non-Small Cell Lung Cancer for Oligometastases and Beyond: How are We Improving Outcomes for Patients?
Patients with Stage IV Lung cancer vary in their response to the numerous systemic therapies and are living longer. The role of aggressive local therapy or metastatic directed therapy (MDT) is critical for radiation oncologists and surgeons.
Category
  • Oligometastatic
  • Thoracic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Radiobiology-guided Innovations in the Integration of Radiation & Immunotherapies
Radiation and immunotherapies are commonly utilized sequentially or concurrently for the treatment of cancer patients, yet we are still developing our understanding of the optimal approaches for safely and effectively integrating these treatments.
Category
  • Immunotherapy
  • Radiobiology
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $0.00
Oligometastatic Prostate Cancer: How Far Do We Go?
There have been many advancements in terms of treatment and imaging modalities for patients with oligometastatic prostate cancer. Failure to understand these advancements in treatment options leads to lower quality of care delivered by clinicians treating prostate cancer patients.
Category
  • Genitourinary
  • Oligometastatic
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00

Pages